Overview Request Sample Pages Request Customization Download PDF
You are viewing: US Animal Parasiticides Market analysis
Part of: Animal Parasiticides Market (Global)

The US Animal Parasiticides Market was valued at $156.82 Million in 2026 and projected to reach to $161.54 Million by 2031, representing a compound annual growth rate of 2.8%. The US animal parasiticides market is positioned for steady growth through 2031, driven by sustained pet ownership trends and increasing consumer investment in animal health.

US Animal Parasiticides Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Animal Parasiticides Market Trends and Insights

  • The US market reflects steady but moderate growth driven by increasing pet ownership, heightened awareness of zoonotic diseases, and regulatory support for animal health products.
  • In the US, the market benefits from strong veterinary infrastructure and consumer spending on companion animal care, though growth remains constrained compared to global trends due to market maturity and established competitive dynamics. The US animal parasiticides sector is characterized by well-established distribution channels, including veterinary clinics, pet retailers, and online platforms.
  • US manufacturers and importers continue to innovate with advanced formulations targeting both companion and livestock segments.
  • Between 2026 and 2031, the US market will experience incremental expansion as preventive care adoption increases and new product launches address emerging parasitic threats.
  • The US regulatory environment, governed by the FDA and EPA, ensures product safety and efficacy, supporting consumer confidence and sustained demand for parasiticide solutions..

Key Market Statistics

  • CAGR (2026-2031) 2.8% CAGR
  • Market Size, 2026 ~USD 156.82 Million
  • Forecast, 2031 ~USD 161.54 Million
  • Country US

US Animal Parasiticides Market Overview

Market Size & Growth :

The US animal parasiticides market is valued at $156.82 million in 2026 and is projected to reach $161.54 million by 2031, with a steady CAGR of 2.8%, reflecting moderate but consistent expansion in the domestic market.

Pet Ownership Surge :

Rising pet ownership across US households is driving increased demand for parasiticide products, as pet owners prioritize preventive healthcare and parasite management for their companion animals.

Zoonotic Disease Awareness :

Growing consumer awareness of zoonotic diseases and their transmission risks has elevated demand for effective parasiticide solutions, particularly among urban and suburban pet owners in the US.

Regulatory Support :

Strong regulatory frameworks and FDA oversight in the US support product innovation and market confidence, enabling manufacturers to introduce advanced parasiticide formulations with enhanced efficacy and safety profiles.

US Animal Parasiticides Market Dynamics

  • Veterinary clinics and pet care facilities continue to recommend parasiticide products as essential preventive treatments, supporting market expansion.
  • The market benefits from established distribution channels, including veterinary practices, pet retailers, and e-commerce platforms, which enhance product accessibility across the country. Looking ahead, the US market will likely see innovation in product formulations, including longer-acting and combination therapies that address multiple parasites simultaneously.
  • Regulatory support and consumer education initiatives will further strengthen market dynamics, though growth will remain moderate compared to global markets, reflecting market maturity and competitive saturation in the domestic landscape..

Related Ecosystem

Animal Health

Top Technologies
  • Polymerase Chain Reaction (PCR) Tests
  • Porcine
  • Immunodiagnostics
  • Lateral Flow Assays
  • Microarrays
Top Companies
  • Zoetis Inc.
  • Patterson Companies, Inc.
  • Virbac
  • Elanco Animal Health Incorporated
  • BOEHRINGER INGELHEIM GMBH

    Key Takeaways

    • The US animal parasiticides market is valued at $156.82 million in 2026 and will reach $161.54 million by 2031 at a 2.8% CAGR.
    • The US market demonstrates steady growth driven by rising pet ownership and increased consumer awareness of parasitic disease prevention.
    • Strong veterinary infrastructure and established distribution networks position the US as a mature, stable market for parasiticide products.
    • The US regulatory framework ensures high product standards, supporting sustained consumer confidence and market stability through 2031.

    Animal Parasiticides Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment DOGS (Livestock Animal)
    Forecast Period 2026–2031
    Growth Rate CAGR of 6.2% from 2026 to 2031
    Largest Segment US (Type)
    Market Size Base Year (Billions) ~USD 12.95 (2026)
    Revenue Forecast (Billions) ~USD 17.5 (2031)
    Segments Covered Type, Animal Type, End User, Livestock Animal, Injectable Type, Product Type

    US Animal Parasiticides Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Type

    • Collars
    • Dips
    • Ear Tags
    • Ectoparasiticides
    • Endectocides
    • Endoparasiticides
    • Feed Additives
    • Injectable Endectocides
    • Injectables
    • Oral Endectocides
    • Oral Liquids
    • Oral Solids
    • Oral Tablets
    • Other Ectoparasiticides
    • Other Endoparasiticides
    • Pour-Ons & Spot-Ons
    • Sprays
    • Topical Endectocides

    By Animal Type

    • Cats
    • Cattle
    • Companion Animals
    • Dogs
    • Horses
    • Livestock
    • Livestock Animals
    • Other Companion Animals
    • Other Livestock
    • Pigs
    • Poultry
    • Sheep & Goats

    By End User

    • Animal Farms
    • Home Care Settings
    • Veterinary Hospitals & Clinics
    • Veterinary Hospitals And Clinics

    By Livestock Animal

    • Cattle
    • Other Livestock
    • Pigs
    • Poultry
    • Sheep & Goats

    By Injectable Type

    • Long-Acting/Extended-Release Injectables
    • Standard/Short-Acting Injectables

    By Product Type

    • Collars
    • Dips
    • Ear Tags
    • Endoparasiticides Feed Additives
    • Endoparasiticides Injectables
    • Endoparasiticides Oral Liquids
    • Endoparasiticides Oral Solids
    • Injectable Endectocides
    • Oral Endectocides
    • Oral Tablets
    • Pour-Ons & Spot-Ons
    • Sprays
    • Topical Endectocides

    Target Audience

    • Pharmaceutical & Veterinary Manufacturers : Manufacturers need detailed US market data to assess market opportunity, competitive positioning, and growth potential for parasiticide product portfolios in the domestic veterinary market.
    • Pet Care & Veterinary Retailers : Retailers require market insights to optimize product selection, inventory management, and sales strategies aligned with US consumer demand for parasiticide products across distribution channels.
    • Investment & Private Equity Firms : Investors need comprehensive US market analysis to evaluate acquisition targets, funding opportunities, and ROI potential in the animal health and parasiticide sector.
    • Veterinary Clinics & Animal Hospitals : Veterinary practitioners benefit from market data to understand treatment trends, product innovations, and consumer preferences to enhance parasiticide recommendations and patient care protocols.
    • Market Research & Consulting Firms : Research professionals require detailed US market segmentation, forecasts, and trend analysis to support client advisory services, competitive intelligence, and strategic planning initiatives.

    Key Companies in the US Animal Parasiticides Market

    CompanyHQOwnershipStrongest segments
    AGRIUM INC.CanadaPrivate CompanyNitrogen-based crop nutrients,Potash,Phosphate-based crop nutrients,
    HENRY SCHEINUnited StatesPublic CompanyGlobal Distribution and Value-Added Services,Global Specialty Products,Global Technology,
    TEREOSFrancePrivate CompanySugar and sweetening ingredients,Starches and plant-based ingredients,Alcohol, ethanol and industrial derivatives,
    PATTERSON COMPANIES, INCUnited StatesPrivate CompanyDental (consumables, equipment, software, services),Animal Health (biologicals, pharmaceuticals, diets, equipment, private label),Corporate and Financing,
    ZOETIS INC.United StatesPublic CompanyCompanion animal pharmaceuticals (parasiticides, dermatology, pain, anti-infectives),Livestock pharmaceuticals and vaccines,Diagnostics (point-of-care, instruments, reference labs, glucose monitors),
    MERCK & CO., INCUnited StatesPublic CompanyOncology (Keytruda, Keytruda Qlex, Welireg, ADC collaborations),Vaccines (Gardasil, pediatric, pneumococcal, rotavirus),Animal Health (livestock, Allflex, companion animal),
    ELANCOUnited StatesPublic CompanyCompanion animal parasiticides (Seresto, K-9 Advantage, Advantix, Advocate, Credelio family, Interceptor Plus, Drontal family),Companion animal vaccines and therapeutics (Galliprant, Atopica, Milbemax, Onsior, Tru Family and other brands),Cattle products (Rumensin, Baytril, Experior and related),
    VIRBACFrancePublic CompanyCompanion-animal parasiticides (Prevexto and related),Companion-animal nutrition & petfood (incl. Vikaly, Ursolyx-linked nutrition),Companion-animal behavior & wellness (Zenidog/Zenifel),
    CEVAUnited StatesPublic Company5G/Cellular Baseband IP (PentaG-RAN, PentaG2, XC20/21/23, Ceva-BX2),Short-Range Connectivity IP (Ceva-Waves Bluetooth/Wi-Fi/UWB/Links/DragonFly),Sensing, Audio, and Motion IP (SensPro, BX1, ClearVox, RealSpace, MotionEngine),
    VETOQUINOLFrancePublic CompanyCompanion animal chronic-care (mobility, pain, dermatology, behavior, cardio-nephrology),Antiparasitics (internal and external) across species,Livestock antibiotics and udder health,
    KRKA, D. D., NOVO MESTOSloveniaPublic CompanyPrescription pharmaceuticals – cardiovascular,Prescription pharmaceuticals – CNS and pain,Prescription pharmaceuticals – GI, diabetes, other,
    ECO - ANIMAL HEALTH LTD.United KingdomPublic CompanyAivlosin (macrolide antibiotic),Endectocides and antiparasitics (Ecomectin, Ecoheart, Ecotraz, Ecomintic),Tetracyclines (Chlortetracycline, Oxytetracycline),
    OUROFINO SAúDE ANIMALBrazilPublic CompanyProduction Animals – Medicines & Vaccines,Production Animals – Additives & Probiotics,Companion Animals – Therapeutics & Preventives,

    AGRIUM INC.

    Agrium Inc. is a Canadian private company founded in 1992 that employs 15,300 people. The company operates in the agricultural sector, providing products and services to support farming operations.

    HENRY SCHEIN

    Henry Schein is a United States-based public company founded in 1932 with 25,000 employees. The company is a major distributor of healthcare products and services to dental, medical, and veterinary professionals.

    TEREOS

    Tereos is a French private company founded in 1996 with 10,241 employees. The company operates in the agribusiness and food processing industries.

    PATTERSON COMPANIES, INC

    Patterson Companies, Inc. is a United States private company founded in 1877 with 7,600 employees. The company is a distributor of dental, animal health, and other professional products and services.

    ZOETIS INC.

    Zoetis Inc. is a United States public company founded in 2012 with 14,500 employees. The company is a leading global manufacturer and distributor of medicines and vaccines for animals.

    MERCK & CO., INC

    Merck & Co., Inc. is a United States public company founded in 1891 with 74,000 employees. The company is a major pharmaceutical and healthcare company producing medicines, vaccines, and animal health products.

    ELANCO

    Elanco is a United States public company founded in 1954 with 9,650 employees. The company is a global animal health company that develops and markets medicines and vaccines for livestock and companion animals.

    VIRBAC

    Virbac is a French public company founded in 1968 with 6,442 employees. The company specializes in the development and distribution of veterinary pharmaceuticals and products for animal health.

    CEVA

    Ceva is a United States public company founded in 1999 with 400 employees. The company operates in the animal health sector.

    VETOQUINOL

    Vetoquinol is a French public company founded in 1933 with 2,454 employees. The company develops and manufactures veterinary pharmaceuticals and health products for companion animals and livestock.

    KRKA, D. D., NOVO MESTO

    Krka, d.d., Novo Mesto is a Slovenian public company founded in 1954 with 13,204 employees. The company is a pharmaceutical manufacturer producing medicines for human and animal health.

    ECO - ANIMAL HEALTH LTD.

    Eco-Animal Health Ltd. is a United Kingdom public company founded in 1972 with 200 employees. The company develops and supplies veterinary pharmaceuticals and animal health products.

    OUROFINO SAúDE ANIMAL

    Ourofino Saúde Animal is a Brazilian public company founded in 1987 with 1,086 employees. The company develops and markets veterinary pharmaceuticals and animal health solutions.

    Reasons to Buy this Report

    • Market Size & Valuation Data : Access precise US market valuation figures ($156.82M in 2026, $161.54M in 2031) with detailed CAGR analysis to benchmark competitive positioning and investment decisions in the domestic parasiticides sector.
    • Growth Driver Insights : Understand key US-specific growth catalysts including pet ownership trends, zoonotic disease awareness, and regulatory support, enabling strategic product development and marketing alignment with market dynamics.
    • Competitive Landscape Analysis : Gain intelligence on the US market structure, distribution channels, and competitive positioning to identify market gaps, partnership opportunities, and expansion strategies within the domestic market.
    • Forecast & Strategic Planning : Leverage 5-year forecast data (2026-2031) to develop long-term business strategies, resource allocation plans, and market entry or expansion initiatives tailored to US market conditions.
    • Regulatory & Consumer Insights : Understand US-specific regulatory frameworks, consumer preferences, and veterinary practice standards to ensure product compliance, market acceptance, and effective go-to-market strategies.

    Frequently asked questions

    What is the current size of the US animal parasiticides market?

    The US animal parasiticides market is estimated at $156.82 million in 2026 and is projected to grow to $161.54 million by 2031.

    What is the growth rate of the US animal parasiticides market?

    The US animal parasiticides market is expected to grow at a compound annual growth rate (CAGR) of 2.8% from 2026 to 2031.

    What factors are driving growth in the US animal parasiticides market?

    Key drivers include increasing pet ownership, heightened awareness of zoonotic diseases, strong veterinary infrastructure, and consumer spending on preventive animal health care.

    Which distribution channels dominate the US animal parasiticides market?

    The US market is served through veterinary clinics, pet retailers, online platforms, and agricultural supply channels for livestock parasiticide products.

    How does the US market compare to global animal parasiticides trends?

    The US market grows at 2.8% CAGR, below the global average of 6.2%, reflecting market maturity and established competitive dynamics in the region.

    RESEARCH METHODOLOGY

    This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.

    Secondary Research

    This research study utilized a variety of comprehensive secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the animal parasiticides market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

    Primary Research

    In the primary research process, a range of sources from both the supply and demand sides were interviewed to gather qualitative and quantitative information for this report. Primary sources from the supply side included project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the animal parasiticides market. Primary sources from the demand side included R&D and product development teams at animal health companies, veterinary clinicians, procurement managers at veterinary hospitals and clinics, and purchasing heads across livestock farms and animal health distribution networks.

    Animal Parasiticides Market Size, and Share

    Note: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million. C-level executives include CEOs, COOs, CTOs, and VPs. Other designations include sales, marketing, and product managers.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The total size of the animal parasiticides market was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.

    Animal Parasiticides Market Top Down and Bottom Up Approach

    Data Triangulation

    After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

    Market Definition

    Animal parasiticides or antiparasitics are medications used to prevent, mitigate, and treat internal and external parasitic infestations in companion and livestock animals. Parasiticides are usually categorized as endoparasiticides, ectoparasiticides, and endectocides. They are available in various formulations, such as oral liquids, tablets, injectables, pour-ons, spot-ons, drenches, ear tags, collars, and sprays. A parasiticide is selected depending on the type of parasite, type of animal, and the number of animals to be treated.

    Key Stakeholders

    • Animal Parasiticide Manufacturers
    • Animal Parasiticide Distributors
    • Animal Health R&D Companies
    • Veterinary Clinics and Hospitals
    • Veterinary Pharmaceutical Associations
    • Veterinary Research Institutes and Universities
    • Venture Capitalists and Investors
    • Market Research and Consulting Firms
    • Government Associations

    Report Objectives

    • To define, describe, segment, and forecast the animal parasiticides market by type, animal type, end user, and region
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market in five main regions (along with their respective key countries): North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players in the market and comprehensively analyze their core competencies and market shares
    • To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships

    Available customizations:

    With the given market data, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:

    Company Information
    • Detailed analysis and profiling of additional market players (up to 5)
    Geographic Analysis
    • Further breakdown of the Rest of Europe animal parasiticides market into Austria, Finland, Switzerland, and other countries
      Further breakdown of the Rest of Latin America animal parasiticides market into Colombia, Chile, and other countries
    Competitive Landscape Assessment
    • Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the animal parasiticides market
    • Competitive leadership mapping for established players in the US

     

    Get the Full Animal Parasiticides Market Report

    Full forecast, segment splits, and company analysis for all Animal Parasiticides Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status